FDA Inspection 1191173 — Caerus Corp

Caerus Corp — FEI 3008216220

The FDA completed an inspection of Caerus Corp on November 22, 2022 in Blaine, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 22, 2022
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Blaine, MN (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures